PharmaBoardroom

Korea’s Commitment to Tackling AMR

Antimicrobial resistance (AMR) is a global health concern that we are increasingly understanding the consequences of and pulling together to try and…

Uğur Bingöl – General Manager, Ibrahim Etem Menarini,…

Uğur Bingöl, general manager of Ibrahim Etem Menarini, speaks of his company’s rapid growth and new product lines. He also describes his take on…

New IFPMA Code Recommends Global Ban on Gifts to Practitioners

Last week, the IFPMA released their new Code of Practice with the aim of encouraging complete integrity and ethical responsibility within the…

Precision Medicine Needs Global Genetic Data

Axel Schumacher, co-founder and chief scientific officer of Shivom, a data-driven next generation precision-medicine company in the blockchain space,…

Paul Henry Huibers – President, Lilly Korea

Paul Henry Huibers, president of Lilly Korea discusses Lilly’s strong double-digit growth following a challenging period of restructuring. Huibers…

Korea: Prioritising AI in Healthcare Innovation

The South Korean government has designated the promotion of artificial intelligence (AI)-based drug development and healthcare innovation as a…

Luis Serrano – President, Centre for Genomic Regulation…

Luis Serrano, president of the Centre for Genomic Regulation (CRG) in Spain, gives an update on the Centre’s recent history and outlines the need…

Jean-Luc Belingard – President, FEFIS, France

Jean-Luc Belingard, president of FEFIS (Fédération Française des Industries de Santé - French Federation of the Health Industry), explains his…

Carlos Rubió – Executive President, Laboratorios Rubió,…

Carlos Rubió, executive president of Laboratorios Rubió, gives an overview of the company’s early years and his priorities now to make the company…

Uloff Münster – General Manager, Merck Biopharma Korea

Uloff Münster, general manager of Merck Biopharma Korea provides his insights into the Korean healthcare system. Dr Münster also discusses the drug…

Jordi Naval – CEO, Biocat, Spain

Jordi Naval, CEO of Biocat, describes the evolution of the BioRegion of Catalonia as an increasingly relevant biotechnology hub in Spain and Europe.…

Jean-Yves Berthon – CEO, GREENTECH, France

Jean-Yves Berthon, CEO of French plant biotechnology pioneers GREENTECH discusses the key milestones in the company’s development trajectory,…

Tagged with A